false
OasisLMS
Catalog
ASGE Annual GI Advanced Practice Provider Course ( ...
Evaluation and Management of IBD
Evaluation and Management of IBD
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, Kimberly Kearns, a nurse practitioner specializing in adult gastroenterology, provides a presentation on the evaluation and management of inflammatory bowel disease (IBD). She discusses the differentiating features between Crohn's disease and ulcerative colitis, the risk factors for developing IBD, and the therapeutic agents used for treatment. Kearns also emphasizes the importance of treat-to-target approach in managing IBD, which involves using defined objective biomarkers, endoscopy, and radiology to prevent progressive bowel damage. She explains the various pharmacological options available, including corticosteroids, 5-ASA agents, immunomodulators, biologic therapies, and small molecules. Kearns also discusses the role of proactive and reactive monitoring in optimizing treatment outcomes and highlights the importance of considering health disparities and equity in the care of patients with IBD. She provides various resources for advanced practice providers in managing IBD and concludes with practice pearls for effective management.
Asset Subtitle
Kimberly Kearns, MS, APN-BC
Keywords
inflammatory bowel disease
Crohn's disease
ulcerative colitis
therapeutic agents
treat-to-target approach
pharmacological options
health disparities
management
×
Please select your language
1
English